Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(Suppl):S220-S227. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0360

View: 2103 Download: 102 Citation: 1

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(2):252-262. Published online March 10, 2023

DOI: https://doi.org/10.3350/cmh.2023.0099

View: 2411 Download: 184 Citation: 1

Editorial

The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(1):99-101. Published online October 27, 2022

DOI: https://doi.org/10.3350/cmh.2022.0321

View: 2125 Download: 70 Citation: 1

Surveillance for hepatocellular carcinoma: It is time to move forward

Bo Hyun Kim, Yuri Cho, Joong-Won Park

Clin Mol Hepatol. 2022;28(4):810-813. Published online September 6, 2022

DOI: https://doi.org/10.3350/cmh.2022.0257

View: 1981 Download: 82 Citations: 4

Original Article

Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area

Bo Hyun Kim, Dahhay Lee, Kyu-Won Jung, Young-Joo Won, Hyunsoon Cho

Clin Mol Hepatol. 2022;28(2):242-253. Published online February 7, 2022

DOI: https://doi.org/10.3350/cmh.2021.0355

View: 3793 Download: 105 Citations: 8

Editorial

Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open

Bo Hyun Kim

Clin Mol Hepatol. 2022;28(2):174-176. Published online January 26, 2022

DOI: https://doi.org/10.3350/cmh.2021.0400

View: 2731 Download: 98 Citation: 1

Letter to the Editor

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?

Bo Hyun Kim

Clin Mol Hepatol. 2019;26(4):579-581. Published online September 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0200

View: 3018 Download: 68 Citations: 2

Review

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2018;24(1):1-9. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0112

View: 12833 Download: 463 Citations: 126

Original Article

Influence of ultrasound contrast agents on spectral Doppler analysis in recipients of liver transplantation

Young Seo Cho, Kyoung Won Kim, Hye Young Jang, Bo Hyun Kim, Jeongjin Lee, Gi Won Song, Sung Gyu Lee, Dagvasumberel Munkhbaatar

Clin Mol Hepatol. 2017;23(3):224-229. Published online July 4, 2017

DOI: https://doi.org/10.3350/cmh.2016.0064

View: 6370 Download: 122 Citation: 1

Co-expression patterns of Notch1, Snail, and p53 in grade III hepatocellular carcinoma with postoperative recurrence: a preliminary study

Sun Kyung Jang, Gi Hong Choi, Junjeong Choi, Xiaoyuan Quan, Jeong Won Jang, Bo Hyun Kim, Guhung Jung, Young Min Park

Clin Mol Hepatol. 2012;18(1):63-74. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.63

View: 6207 Download: 44 Citations: 2

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus

Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park

Clin Mol Hepatol. 2011;17(3):199-205. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.199

View: 6612 Download: 59 Citations: 17

Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results

Ja Seon Kim, Young Min Park, Nha Young Kim, Han Kyeol Yun, Ki Jong Lee, Bo Hyun Kim, Sang Jong Park, Jae Woo Yeon, Guhung Jung

Clin Mol Hepatol. 2011;17(2):120-129. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.120

View: 6776 Download: 59 Citations: 5

1 |

Viewed By 7042	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 6147	A decade of liver organoids: Advances in disease modeling
Viewed By 3244	MAFLD: How is it different from NAFLD?
Viewed By 2775	Management of refractory ascites
Viewed By 2672	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 117	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 54	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 52	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 46	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 45	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Search